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Net Effect of Lymphaticovenous Anastomosis on Volume Reduction of Peripheral
Lymphoedema after Complex Decongestive Physiotherapy
W. Wisselink*
VU University Medical Center, Department of Vascular Surgery, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The NetherlandsAlthough we have come a long way from atrocities such as
circumferential excision of all lymphoedematous tissue, modern
microsurgical techniques to date have not been scrutinised sufﬁ-
ciently to fully establish their role in the treatment of chronic
lymphoedema.
In an admirable effort, at least, the authors have tried to isolate
the effect of microsurgically created lymphovenous anastomoses
from that of the concomitant decompressive regiments that these
often desperate patients tend to undergo.
Relative to the effects of complex lymphoedema therapy (CLT),
the volume reduction obtained with side-to-end lymphovenous
anastomosis is modest, at best, even if six or more of such anas-
tomoses have been created. Other parameters of successful therapy
such as a reduction in the incidence of cellulitis, increased softness
of the limbs or improved quality of life have not been studied.
Remarkably, the authors do not report any adverse effects of their
surgical therapy; in fact, they do not evenmention the possibility of
complications at all. Any surgical therapy has its down side and at
least the theoretical possibility of making a condition worse
warrants attention in any surgical paper. As many studies reportDOI of original article: 10.1016/j.ejvs.2011.12.032.
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doi:10.1016/j.ejvs.2012.02.013a high rate of occlusion of the lymphovenous connections, some
objective measure of patency should be introduced to evaluate this
therapy. Also, exciting alternatives or adjunctive measures such as
the use of growth factors (Vascular Endothelial Growth Factor-C
(VEGF-C) and Vascular Endothelial Growth Factor-D (VEGF-D)) that
selectively stimulate the growth of lymphatic vessels, with or
without the addition of autologous lymph node transfer1 and low-
level laser therapy,2 should be evaluated.
With these shortcomings, nevertheless, this is an interesting
article on an area of clinical importance that further stresses the
necessity of prospective randomised studies to elucidate the rela-
tive effects of different therapeutic measures to the beneﬁt of
patients suffering from chronic lymphoedema.
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